Document Detail

The consequences of rheumatoid arthritis: quality of life measures in the individual patient.
MedLine Citation:
PMID:  16273784     Owner:  NLM     Status:  MEDLINE    
Despite conventional treatment, RA still has many deleterious consequences. From the patients' perspective, these include persistent pain, functional disability, fatigue, and depression modified by health beliefs and underlying psychological problems. Disability is a consequence of pain, active synovitis and joint damage. It is usually assessed by self-reported questionnaire; the Health Assessment Questionnaire (HAQ) remains the dominant disability measure, although generic health measures such as Short Form-36 and Nottingham Health Profile provide similar information. Treatment with disease modifying drugs and biologic agents improves pain, fatigue and disability. We specifically evaluated the effects of both these drugs and also disease duration on disability assessed by HAQ scores, as there is most information on this topic and it is of fundamental importance to patients. In early RA HAQ gives a 'J-shaped' curve; the initial fall is due to the immediate benefits of treatment and the subsequent gradual rise due to the inability of therapy to fully suppress the disease or prevent progressive joint damage. In established RA HAQ scores increase by about 1% annually and over 25 years average HAQ scores increase by 1.0. Disease modifying drugs and biologics both significantly reduce HAQ scores and the reduction is maintained for 2-5 years. This reduction is seen in both early and established disease. Early steroid therapy has immediate symptomatic treatment, but does not have long-term benefits. Over 5 years the impact of aggressive therapy with disease modifying drugs declines and there is evidence that insufficient treatment is given to many patients with RA. The outcome of RA is greatly improved by current treatment with disease modifying drugs and biologic agents. However, more needs to be done and achieving better results is enhanced by routinely measuring the impact of the disease in routine practice.
L Pollard; E H Choy; D L Scott
Related Documents :
12972474 - Detection of cases of inflammatory rheumatic disorders: performance of a telephone ques...
22609474 - Possible impact of adrb3 trp64arg polymorphism on bmi in patients with schizophrenia.
25041254 - Measurement of thirst in chronic heart failure- a review.
9295454 - Off-the-shelf orthopedic footwear for people with rheumatoid arthritis.
20875514 - Relationship between the western ontario and mcmaster universities osteoarthritis index...
18595964 - Patient factors used by pediatricians to assign asthma treatment.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Clinical and experimental rheumatology     Volume:  23     ISSN:  0392-856X     ISO Abbreviation:  Clin. Exp. Rheumatol.     Publication Date:    2005 Sep-Oct
Date Detail:
Created Date:  2005-11-08     Completed Date:  2006-01-24     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8308521     Medline TA:  Clin Exp Rheumatol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  S43-52     Citation Subset:  IM    
Department of Rheumatology, GKT School of Medicine, Weston Education Centre, Kings College, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arthritis, Rheumatoid / complications*,  physiopathology*,  therapy
Disability Evaluation
Health Status
Outcome Assessment (Health Care)
Pain / etiology,  physiopathology*
Quality of Life*
Rheumatology / methods*
Severity of Illness Index

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Measuring functional disability in early rheumatoid arthritis: the validity, reliability and respons...
Next Document:  The promise of PROMIS: using item response theory to improve assessment of patient-reported outcomes...